ADIM
CVS icon

Alpha DNA Investment Management’s CVS Health CVS Stock Holding History

Alpha DNA Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,800
Closed -$1.41M – 163
2022
Q3 		$1.41M Buy
+14,800
New +$1.46M 1.17% 12
2022
Q2 		– Sell
-14,376
Closed -$1.45M – 127
2022
Q1 		$1.45M Buy
+14,376
New +$1.51M 1.02% 13
2021
Q2 		– Sell
-1,078
Closed -$80K – 219
2021
Q1 		$80K Buy
1,078
+113
+12% +$8.23K 0.09% 131
2020
Q4 		$65K Buy
+965
New +$62.8K 0.07% 149

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's CVS Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of CVS Health (CVS) in Q4 2022, closing a stake of 14,800 shares — an estimated $1.41M sold.

Alpha DNA Investment Management first reported a position in CVS in Q4 2020 and held it in 4 quarters. The position peaked at $1.45M in Q1 2022. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 14,800 CVS Health shares in Q4 2022, an estimated $1.41M.
  • Alpha DNA Investment Management first reported a position in CVS Health in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's CVS Health position peaked at $1.45M in Q1 2022.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.